Sign inGet started

Jayasuriya Anula

Insider CIK 1822933 · JAGX Director · LCTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LCTX Lineage Cell Therapeutics, A Award deriv2026-07-012026-07-02125,000— $0125,000SEC↗
JAGX Jaguar Health, Inc. A Award deriv2025-12-112025-12-155,870— $05,870SEC↗
JAGX Jaguar Health, Inc. A Award2025-12-112025-12-155,870— $05,916SEC↗
LCTX Lineage Cell Therapeutics, A Award deriv2025-07-012025-07-0275,000— $075,000SEC↗
JAGX Jaguar Health, Inc. A Award deriv2024-10-082024-10-1021,000— $021,000SEC↗
LCTX Lineage Cell Therapeutics, A Award deriv2024-07-012024-07-0375,000— $075,000SEC↗
LCTX Lineage Cell Therapeutics, P Buy2023-12-292024-01-0210,000$1.09 $10.9K10,000SEC↗
JAGX Jaguar Health, Inc. A Award2023-08-142023-08-1468,568— $070,286SEC↗
LCTX Lineage Cell Therapeutics, A Award deriv2023-07-012023-07-0350,000— $050,000SEC↗
JAGX Jaguar Health, Inc. A Award deriv2023-07-012023-08-141,718— $00SEC↗
JAGX Jaguar Health, Inc. A Award2023-07-012023-08-141,718— $01,718SEC↗
JAGX Jaguar Health, Inc. A Award deriv2023-04-062023-04-061,718— $01,718SEC↗
LCTX Lineage Cell Therapeutics, A Award deriv2022-07-012022-07-0650,000— $050,000SEC↗
LCTX Lineage Cell Therapeutics, A Award deriv2021-07-012021-07-0150,000— $050,000SEC↗
LCTX Lineage Cell Therapeutics, A Award deriv2021-05-042021-05-0690,000— $090,000SEC↗